{"OMIM ID": "OMIM:615501", "DISEASE": "Molybdenum Cofactor Deficiency, Complementation Group C", "RECORD": "Rare disease patients have complex clinical representations. Patients with Molybdenum Cofactor Deficiency, Complementation Group C present clinical features that include, but are not limited to, aplastic anemia, severe neutropenia, developmental delay, intellectual disability, and skeletal abnormalities.\n\nMolybdenum Cofactor Deficiency, Complementation Group C is caused by mutations in the SLC40A1 gene and is inherited in an autos. Some special cases also present with features of a mitochondrial disorder.\n\nMolybdenum Cofactor Deficiency, Complementation Group C is a rare disease and is estimated to affect less than 1 in 1,000,000 people in the USA.. The main symptomatic differences of Molybdenum Cofactor Deficiency, Complementation Group C from similar diseases is that it is inherited in an autosomal recessive manner.\n\nMolybdenum Cofactor Deficiency, Complementation Group C is a rare disease and is estimated to affect less than 1 in 1,000,000 people in the USA.. The main symptomatic differences of Molybdenum Cof", "SUMMARY": "actor Deficiency, Complementation Group C from similar diseases is that it is inherited in an autosomal recessive manner.\n\nMolybdenum Cofactor Deficiency, Complementation Group C is a rare disease and is estimated to affect"}